Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Aug 15, 2026
Schwab U.S. Dividend Equity ETF (SCHD) Delivers +6.7% 30-Day Gain on Defensive Income Tilt

Schwab U.S. Dividend Equity ETF (SCHD) Delivers +6.7% 30-Day Gain on Defensive Income Tilt

Key Takeaways

  • SCHD tracks the Dow Jones U.S. Dividend 100 Index, holding approximately 103 dividend-paying U.S. companies through a rules-based quality, yield, and dividend-growth screen.
  • The ETF's latest 30-day price move was roughly +6.7%, a steady advance that remained below the threshold for high-momentum or high-volatility positioning.
  • Over the most recent quarter, SCHD rose about 8.8% on a price basis, supported by health care, financials, information technology, and industrial sector strength within the portfolio.
  • Health care, consumer staples, energy, and technology are the fund's largest sector exposures, giving the portfolio a defensive income tilt with select cyclical drivers.
  • The fund carries a 0.06% expense ratio and manages roughly $100 billion in assets under management (AUM).
  • Key considerations include sector concentration, value and dividend-style rotation, interest-rate expectations, and the earnings resilience of its largest holdings.

Schwab U.S. Dividend Equity ETF (SCHD) Overview

The SCHD is a passively managed exchange-traded fund designed to track the Dow Jones U.S. Dividend 100 Index. The index targets high-dividend-yielding U.S. companies with a record of consistent payouts, then applies fundamental screens based on financial strength relative to industry peers. This rules-based approach produces a portfolio of about 103 large-cap, dividend-paying stocks rather than a simple highest-yield list.

Largest positions recently included Abbott Laboratories, UnitedHealth Group, Merck, Home Depot, Amgen, Procter & Gamble, Coca-Cola, Chevron, PepsiCo, Verizon Communications, and Texas Instruments. Sector exposure is concentrated in health care, consumer staples, energy, and technology, with smaller allocations to financials, industrials, consumer discretionary, and communication services. The fund's low 0.06% expense ratio and quarterly distribution schedule reinforce its role as a cost-efficient equity income vehicle. I also checked this using Tickeron’s AI Screener to see how the ETF compares to peers in the dividend space.

Industry and Thematic Landscape

The broader market environment for dividend and equity income strategies has been defined by a rotation toward cash-flow-generative, fundamentally sound companies. Sectors such as health care and consumer staples offer defensive earnings streams, while energy and financials add sensitivity to commodity prices, credit conditions, and interest rates. Technology exposure within dividend strategies has also become more relevant as mature semiconductor and software-related companies return capital to shareholders.

For SCHD, this sector mix matters because the fund's performance is shaped less by a single macroeconomic theme and more by the interaction of defensive income demand, value rotation, and the earnings trajectory of large-cap dividend payers. In an environment where investors continue to evaluate inflation, monetary policy, and economic growth, quality dividend exposure has remained a central investment theme.

Performance and Positioning Snapshot

SCHD's latest available close of $34.52 compares with a close of roughly $32.34 about 30 calendar days earlier, representing a gain of approximately 6.7% on a price basis. The advance was gradual and trend-driven rather than volatile, with the fund moving steadily higher before consolidating near recent highs. Over the most recent quarter, SCHD advanced from about $31.72 to $34.52, a move of roughly 8.8%.

The fund's sector sleeve performance helps explain the trend. Health care, financials, information technology, and industrials were among the stronger areas within the portfolio during the latest quarter, while energy and consumer staples were more mixed. That combination allowed SCHD to benefit from defensive health care leadership and select cyclical recovery without depending entirely on a single sector. Major holdings in managed care, pharmaceuticals, home improvement retail, and semiconductors contributed to the fund's positioning during the period. I reviewed the latest signals on this using Tickeron’s AI Trend Prediction Engine to confirm the broader sector momentum.

2026 Outlook and Key Factors to Monitor

Several structural factors are likely to influence SCHD during 2026. The health care sector will remain important given the fund's largest exposure, with attention on pharmaceutical pipelines, managed-care pricing, and regulatory developments. Consumer staples performance will depend on pricing power, volume trends, and the ability of large branded companies to defend margins. Energy holdings remain tied to commodity prices, capital discipline, and global demand, while financials are sensitive to credit conditions and interest-rate expectations.

Technology exposure may be influenced by semiconductor demand, enterprise spending, and shareholder-return policies. Dividend growth, payout ratios, and any changes to the underlying index's selection methodology also matter for portfolio composition. Finally, capital flows into dividend ETFs, competition from lower-cost or higher-yield products, and the broader macroeconomic environment—including inflation trends, monetary policy, and economic growth—will help determine whether defensive income leadership persists or broadens. Investors should monitor these themes rather than rely on short-term price movements alone.

Tickeron AI Tools for Research

In my own analysis, I find Tickeron’s AI Screener particularly useful for quickly scanning dividend-focused ETFs and comparing sector exposures against broader market trends. The platform pulls together technical indicators, fundamentals, and AI-generated signals in one place, which helps streamline the process of evaluating holdings like those in SCHD without spending hours on manual screens. Explore the AI Screener to see how data-driven discovery can support a more disciplined research process.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SCHD

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


SCHD in downward trend: price dove below 50-day moving average on September 16, 2026

SCHD moved below its 50-day moving average on September 16, 2026 date and that indicates a change from an upward trend to a downward trend. In 42 of 53 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SCHD moved out of overbought territory on August 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 31 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCHD as a result. In 56 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 67%.

The Moving Average Convergence Divergence Histogram (MACD) for SCHD turned negative on August 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 35 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

The Aroon Indicator for SCHD entered a downward trend on September 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 278 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

SCHD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Notable companies

The most notable companies in this group are ABBVIE (NYSE:ABBV), Cisco Systems (NASDAQ:CSCO), Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Merck & Co (NYSE:MRK), Home Depot (NYSE:HD), Texas Instruments (NASDAQ:TXN), Amgen (NASDAQ:AMGN), Verizon Communications (NYSE:VZ), PepsiCo (NASDAQ:PEP).

Industry description

The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100™ Index. To pursue its goal, the fund generally invests in stocks that are included in the index. The index is designed to measure the performance of high dividend yielding stocks issued by U.S. companies that have a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios. The fund will invest at least 90% of its net assets in these stocks.

Market Cap

The average market capitalization across the Schwab US Dividend Equity ETF (SCHD) ETF is 52.96B. The market cap for tickers in the group ranges from 426.43M to 466.45B. ABBV holds the highest valuation in this group at 466.45B. The lowest valued company is OXM at 426.43M.

High and low price notable news

The average weekly price growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was -1%. For the same ETF, the average monthly price growth was -4%, and the average quarterly price growth was 13%. DINO experienced the highest price growth at 7%, while VRTS experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was 184%. For the same stocks of the ETF, the average monthly volume growth was 120% and the average quarterly volume growth was -42%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 33
P/E Growth Rating: 43
Price Growth Rating: 50
SMR Rating: 42
Profit Risk Rating: 56
Seasonality Score: -10 (-100 ... +100)
View a ticker or compare two or three
SCHD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category LargeValue

Profile
Details
Category
Large Value
Address
Schwab Strategic Trust101 Montgomery StreetSan Francisco
Phone
1-800-435-4000
Web
www.csimfunds.com.
Interact to see
Advertisement
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.
AAOI shares surged approximately 10.90% in premarket trading on March 18, 2026, rising from a prior close of $86.33 to $95.74. The primary catalyst is strong positive sentiment generated at OFC 2026 — the Optical Fiber Communications Conference and Exhibition — where Applied Optoelectronics unveiled breakthrough laser and transceiver technology for next-generation AI data center infrastructure.
LITE shares surged approximately +12% in early Wednesday trading on March 18, 2026, with the stock changing hands near $727 compared to a prior session close of $649.56. The primary near-term catalyst is Lumentum's S&P 500 index inclusion, effective March 23, 2026, triggering front-running by institutional investors and mandatory buying by passive index funds.
Shares of New Era Energy & Digital, Inc. (NUAI) are trading down approximately 17% during today's session, with the prior close sitting at $5.56. The decline follows the company's March 17 business update conference call and webcast, held after market hours, during which management discussed the recently filed fiscal year 2025 annual report (Form 10-K).
Shares of Regencell Bioscience Holdings (RGC) are up approximately +16% intraday on March 18, 2026, trading at $26.56 against a prior close of $22.97. No single company-specific press release is driving today's move; the rally is primarily fueled by retail-driven momentum and short squeeze mechanics.
A jump in the Producer Price Index from 0.3% to around 0.7% month‑over‑month signals that wholesale inflation is re‑accelerating, delaying Fed rate‑cut hopes and reviving the “higher for longer” rates narrative.business. Likely winners in this environment include energy and commodity producers (XOM, CVX, TTE, COP), inflation‑resilient financials (JPM, BAC), and real‑asset plays like pipelines and infrastructure, which can pass through higher prices; ETFs like XLE, XOP, XLF, DBA, GLD offer diversified exposure.
BGSI fell more than 11% today, pulling back from recent levels around the high‑$150s as investors reassessed the risk‑reward following the Q4 2025 print and major U.S. expansion plans. Full‑year 2025 sales rose 2.4% to US$3.14 billion, but same‑store sales declined 0.2%, while reported net earnings fell 25% to US$18.4 million due to US$22.6 million in acquisition and transformation costs.